FDA Asks for More Info on EnteroMedics' Weight Loss Implant

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Weight-loss devices maker EnteroMedics says it's still on track with its premarket approval application, expecting a decision early next year despite the FDA's request for more information. Minnesota medical device maker EnteroMedics (NSDQ:ETRM) appeared unfazed by the FDA's response to the company's premarket approval application, anticipating no slowdown in the regulatory process for its landmark Maestro weight-loss implant.

Help employers find you! Check out all the jobs and post your resume.

Back to news